Literature DB >> 7585946

A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma.

S Winandy1, P Wu, K Georgopoulos.   

Abstract

The Ikaros gene is essential for lymphoid lineage specification. As previously reported, mice homozygous for a mutation in the Ikaros DNA-binding domain fail to generate mature lymphocytes as well as their earliest described progenitors. In addition, our studies with mice heterozygous for this mutation establish the Ikaros gene as an essential regulator of T cell proliferation. Thymocytes display augmented TCR-mediated proliferative responses, and peripheral T cells are autoproliferative. A general lymphoproliferation precedes the T cell leukemia and lymphoma that rapidly develop in all heterozygotes. The first step toward leukemic transformation occurs within the maturing thymocyte population and is demarcated by clonal expansions and loss of the single Ikaros wild-type allele. From these studies, we propose that within developing and mature T lymphocytes, distinct thresholds of Ikaros activity are required to regulate proliferation. A decrease in Ikaros activity below the first threshold causes the rapid accumulation of T lymphoblasts, whereas a further decrease leads to neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585946     DOI: 10.1016/0092-8674(95)90170-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  159 in total

1.  Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.

Authors:  J Koipally; A Renold; J Kim; K Georgopoulos
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

2.  CD3-epsilon overexpressed in prothymocytes acts as an oncogene.

Authors:  B Wang; J She; M Salio; D Allen; E Lacy; N Lonberg; C Terhorst
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

3.  Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition.

Authors:  Pablo Gómez-del Arco; Kazushige Maki; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

4.  Ikaros limits basophil development by suppressing C/EBP-α expression.

Authors:  Kavitha N Rao; Craig Smuda; Gregory D Gregory; Booki Min; Melissa A Brown
Journal:  Blood       Date:  2013-08-29       Impact factor: 22.113

5.  Ikaros SUMOylation: switching out of repression.

Authors:  Pablo Gómez-del Arco; Joseph Koipally; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  Ikaros integrates endocrine and immune system development.

Authors:  Shereen Ezzat; Rene Mader; ShunJiang Yu; Terry Ning; Philippe Poussier; Sylvia L Asa
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

7.  Ikaros promotes early-born neuronal fates in the cerebral cortex.

Authors:  Jessica M Alsiö; Basile Tarchini; Michel Cayouette; Frederick J Livesey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 8.  Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.

Authors:  Chandrika Gowda; Chunhua Song; Malika Kapadia; Jonathon L Payne; Tommy Hu; Yali Ding; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2016-09-18

9.  Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.

Authors:  Shaun O'Brien; Rajan M Thomas; Gerald B Wertheim; Fuqin Zhang; Hao Shen; Andrew D Wells
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

10.  Role of a non-canonical splice variant of the Helios gene in the differentiation of acute lymphoblastic leukemic T cells.

Authors:  Yinghui Li; Yanhua Liu; Can Liu; Fengyong Liu; Daolei Dou; Wenjie Zheng; Wei Liu; Feifei Liu
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.